P1448 Ablation of cti-dependent flutter using a novel advanced mini-electrodes technology: preliminary results from Leonardo reg
![Frontiers | Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review Frontiers | Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review](https://www.frontiersin.org/files/MyHome%20Article%20Library/928621/928621_Thumb_400.jpg)
Frontiers | Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
![Frontiers | A multiscale mechanistic model of human dendritic cells for in-silico investigation of immune responses and novel therapeutics discovery Frontiers | A multiscale mechanistic model of human dendritic cells for in-silico investigation of immune responses and novel therapeutics discovery](https://www.frontiersin.org/files/Articles/1112985/fimmu-14-1112985-HTML-r1/image_m/fimmu-14-1112985-g001.jpg)
Frontiers | A multiscale mechanistic model of human dendritic cells for in-silico investigation of immune responses and novel therapeutics discovery
![Ablation of CTI-dependent flutter using different ablation technologies: acute and long-term outcome from the LEONARDO study | Request PDF Ablation of CTI-dependent flutter using different ablation technologies: acute and long-term outcome from the LEONARDO study | Request PDF](https://i1.rgstatic.net/publication/369011916_Ablation_of_CTI-dependent_flutter_using_different_ablation_technologies_acute_and_long-term_outcome_from_the_LEONARDO_study/links/640405110cf1030a56713f9a/largepreview.png)